ESM Technologies, (DBA Stratum Nutrition), the leading supplier of innovative, commercialized eggshell and eggshell membrane wellness ingredients, has received the Frost & Sullivan 2011 North American Dietary Supplements for Joint Health New Product Innovation of the Year Award for their NEM® ingredient. Over 600,000 tons of eggshells are disposed of in U.S. landfills each year, and ESM Technologies has found a clinically proven use for these eggshells.
Frost & Sullivan recognizes ESM Technologies with this award for NEM® based on several criteria: innovative element of the product, leveraging leading-edge technologies, value-added features and benefits, increased customer return on investment (ROI), as well as customer acquisition and penetration potential. NEM® has a competitive advantage over other joint health products due to its small dosage and quick effect.
“The NEM® product developed by ESM Technologies not only meets the patients’ requirement for a safe, natural and effective product but also meets the industry’s requirement of sustainable production,” said Lalithambigai Ananthan, research analyst for Frost & Sullivan. “The New Product Innovation Award is a prestigious recognition of ESM Technologies’ accomplishments in the field of Dietary Supplements for Joint Health. For the development of these novel products, ESM Technologies owns an extensive patent portfolio and continues to generate patent worthy technologies.”
Multiple clinical trials have been conducted on NEM®, and it is proven to improve joint comfort and flexibility in just 7-10 days with a small, 500mg dose per day. “NEM® not only supports arthritic patients, but also athletes, sportspersons and the general public who want to improve their joint health,” said Ananthan. NEM® has also recently received self-affirmed GRAS (Generally Recognized As Safe) status, which allows for its expansion into the food and beverage markets.
“We are honored to receive this award from Frost & Sullivan,” said President of ESM Technologies Micah Osborne. “We feel that this is an independent validation of our team’s hard work on NEM®. NEM® is the fastest working, clinically effective joint health ingredient in a small 500 milligram dose. These qualities have made it a success with consumers as well as our industry partners.”
About Frost & Sullivan:
Frost & Sullivan enables companies to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company’s Growth Partnership Service provides the CEO and the CEO’s Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. We leverage 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from over 40 offices on six continents.